Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
Titel:
Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
Auteur:
Jabbour, Elias Jones, Daniel Kantarjian, Hagop M. O'Brien, Susan Tam, Constantine Koller, Charles Burger, Jan A. Borthakur, Gautam Wierda, William G. Cortes, Jorge